- Home
- SNTI vs MDJH Comparison
SNTI vs MDJH Comparison
Compare SNTI & MDJH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- MDJH
- Stock Information
- Founded
- SNTI 2016
- MDJH 2002
- Country
- SNTI United States
- MDJH United Kingdom
- Employees
- SNTI N/A
- MDJH N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- MDJH Real Estate
- Sector
- SNTI Health Care
- MDJH Finance
- Exchange
- SNTI Nasdaq
- MDJH Nasdaq
- Market Cap
- SNTI 14.1M
- MDJH 13.6M
- IPO Year
- SNTI N/A
- MDJH 2019
- Fundamental
- Price
- SNTI $2.24
- MDJH $0.65
- Analyst Decision
- SNTI
- MDJH
- Analyst Count
- SNTI 0
- MDJH 0
- Target Price
- SNTI N/A
- MDJH N/A
- AVG Volume (30 Days)
- SNTI 19.6K
- MDJH 79.3K
- Earning Date
- SNTI 11-11-2024
- MDJH 01-01-0001
- Dividend Yield
- SNTI N/A
- MDJH N/A
- EPS Growth
- SNTI N/A
- MDJH N/A
- EPS
- SNTI N/A
- MDJH N/A
- Revenue
- SNTI $338,000.00
- MDJH $114,849.00
- Revenue This Year
- SNTI $254.47
- MDJH N/A
- Revenue Next Year
- SNTI $169.66
- MDJH N/A
- P/E Ratio
- SNTI N/A
- MDJH N/A
- Revenue Growth
- SNTI N/A
- MDJH 289.97
- 52 Week Low
- SNTI $1.52
- MDJH $0.59
- 52 Week High
- SNTI $8.48
- MDJH $2.19
- Technical
- Relative Strength Index (RSI)
- SNTI 37.17
- MDJH 33.85
- Support Level
- SNTI $2.05
- MDJH $0.60
- Resistance Level
- SNTI $2.46
- MDJH $0.67
- Average True Range (ATR)
- SNTI 0.25
- MDJH 0.05
- MACD
- SNTI -0.09
- MDJH 0.01
- Stochastic Oscillator
- SNTI 15.32
- MDJH 21.59
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About MDJH MDJM LTD
MDJM Ltd is a real estate service company. The company provides real estate agency services to real estate developer clients, as well as real estate consulting services and independent training services on an as-needed basis. It offers consulting, marketing planning, advertising services, and sales strategies to real estate clients. The company income is derived from commission-based services and minimal consulting and other services. The company has two operating segments; the real estate agent services segment and the hospitality business segment. It derives a majority of its revenue from the People's Republic of China.